China Resources Double-Crane Pharmaceutical Co.,Ltd. Stock
Stocks
600062
CNE000000Q94
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.93 CNY | -3.26% |
|
+3.04% | -7.44% |
| 07-15 | China Resources Pharma Unit Emerges Top Bidder for Lier Chemical Stake | MT |
| 07-06 | China Approves Double-Crane Pharmaceutical's Progesterone Capsules | MT |
| Market Cap | 17.49B 2.58B 2.25B 2.08B 1.92B 3.61B 248B 3.69B 24.86B 9.78B 122B 9.69B 9.48B 419B | P/E 2026 * |
9.99x | P/E 2027 * | 9.38x |
|---|---|---|---|---|---|
| Enterprise Value | 17.49B 2.58B 2.25B 2.08B 1.92B 3.61B 248B 3.69B 24.86B 9.78B 122B 9.69B 9.48B 419B | EV / Sales 2026 * |
1.51x | EV / Sales 2027 * | 1.44x |
| Free-Float |
37.82% | Yield 2026 * |
3.01% | Yield 2027 * | 3.13% |
| 1 day | -3.26% | ||
| 1 week | +3.04% | ||
| Current month | +5.55% | ||
| 1 month | +1.01% | ||
| 3 months | -9.08% | ||
| 6 months | -8.68% | ||
| Current year | -7.44% |
| 1 week | 16.49 |  | 17.65 |
| 1 month | 15.29 | | 17.65 |
| Current year | 15.29 | | 19.08 |
| 1 year | 15.29 | | 22.14 |
| 3 years | 14.8 | | 26.15 |
| 5 years | 10.95 | | 37.44 |
| 10 years | 10.66 | | 37.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Zhao
PSD | President | - | 2024-10-24 |
Wen Chao Lu
PSD | President | - | 2023-09-20 |
Li Hong Zheng
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mao Zhu Sun
BRD | Director/Board Member | 67 | 2021-07-11 |
Ning Liu
BRD | Director/Board Member | 68 | 2010-05-31 |
Wei Zheng
BRD | Director/Board Member | 66 | 2018-06-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/21/22 | Buy | Chairman | 5,000 | 0.0005% | ||
| 12/21/22 | Buy | Director | 10,000 | 0.0010% | ||
| 12/20/22 | Buy | Director | 5,000 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.26% | +3.04% | -12.14% | +0.95% | 2.67B | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,043B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 602B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 449B | |
| +0.78% | -0.39% | +30.44% | +23.23% | 327B | |
| +1.41% | +0.56% | +31.41% | +47.13% | 279B | |
| -0.27% | -5.69% | +20.68% | +21.99% | 264B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 201B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 169B | |
| -0.36% | +3.64% | +1.91% | -30.15% | 143B | |
| Average | -0.27% | -0.48% | +26.16% | +50.88% | 347.97B | |
| Weighted average by Cap. | +0.42% | -1.81% | +39.72% | +84.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.59B 1.71B 1.49B 1.38B 1.27B 2.4B 165B 2.45B 16.48B 6.48B 80.66B 6.42B 6.28B 278B | 12.18B 1.8B 1.57B 1.45B 1.34B 2.52B 173B 2.57B 17.32B 6.81B 84.75B 6.75B 6.6B 292B |
| Net income | 1.76B 259M 227M 209M 193M 363M 24.96B 371M 2.5B 983M 12.23B 973M 952M 42.09B | 1.87B 276M 241M 223M 205M 387M 26.61B 396M 2.66B 1.05B 13.03B 1.04B 1.01B 44.87B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | CN¥16.93 | -3.26% | 13,963,840 |
| 26-07-16 | CN¥17.50 | +1.45% | 16,915,936 |
| 26-07-15 | CN¥17.25 | +2.31% | 15,295,615 |
| 26-07-14 | CN¥16.86 | +0.96% | 9,293,813 |
| 26-07-13 | CN¥16.70 | +0.78% | 8,760,650 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600062 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
